ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Nuclide Therapeutics Ltd

Nuclide Therapeutics Ltd is an active company incorporated on 22 May 2024 with the registered office located in London, Greater London. Nuclide Therapeutics Ltd was registered 1 year 4 months ago.
Status
Active
Active since incorporation
Company No
15734758
Private limited company
Age
1 year 4 months
Incorporated 22 May 2024
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 21 May 2025 (4 months ago)
Next confirmation dated 21 May 2026
Due by 4 June 2026 (8 months remaining)
Last change occurred 4 months ago
Accounts
Not Submitted
Awaiting first accounts
For period ending 31 May 2025
Due by 22 February 2026 (4 months remaining)
Address
124 City Road
London
EC1V 2NX
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
5
Shareholders
4
Controllers (PSC)
1
Director • Scientist • British • Lives in UK • Born in Nov 1983
Director • Scientist • Portuguese • Lives in UK • Born in Dec 1985
Director • Scientist • Turkish • Lives in UK • Born in Aug 1985
Director • Scientist • British • Lives in UK • Born in Aug 1988
Director • Investor Director • German • Lives in Germany • Born in Oct 1970
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
No mutual companies found
Financials
Nuclide Therapeutics Ltd has not yet submitted any accounts
Period Ended
Due Soon
Cash in Bank
Due Soon
Turnover
Due Soon
Employees
Due Soon
Total Assets
Due Soon
Total Liabilities
Due Soon
Net Assets
Due Soon
Debt Ratio (%)
Due Soon
Latest Activity
Mr Matthias Unitz Details Changed
1 Month Ago on 28 Aug 2025
Mr Matthias Unitz Appointed
2 Months Ago on 31 Jul 2025
Confirmation Submitted
4 Months Ago on 5 Jun 2025
Notification of PSC Statement
1 Year 3 Months Ago on 18 Jun 2024
Timothy Howard Witney (PSC) Resigned
1 Year 3 Months Ago on 13 Jun 2024
Richard Sherburne Edwards (PSC) Resigned
1 Year 3 Months Ago on 13 Jun 2024
Dr Sofia Nascimento Dos Santos Appointed
1 Year 3 Months Ago on 13 Jun 2024
Dr Muhammet Tanc Appointed
1 Year 3 Months Ago on 13 Jun 2024
Incorporated
1 Year 4 Months Ago on 22 May 2024
Get Credit Report
Discover Nuclide Therapeutics Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Director's details changed for Mr Matthias Unitz on 28 August 2025
Submitted on 28 Aug 2025
Particulars of variation of rights attached to shares
Submitted on 4 Aug 2025
Change of share class name or designation
Submitted on 4 Aug 2025
Memorandum and Articles of Association
Submitted on 4 Aug 2025
Resolutions
Submitted on 4 Aug 2025
Sub-division of shares on 31 July 2025
Submitted on 4 Aug 2025
Statement of capital following an allotment of shares on 31 July 2025
Submitted on 4 Aug 2025
Appointment of Mr Matthias Unitz as a director on 31 July 2025
Submitted on 31 Jul 2025
Confirmation statement made on 21 May 2025 with updates
Submitted on 5 Jun 2025
Resolutions
Submitted on 16 Jul 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year